key: cord-0800711-qjl5xaq4
authors: Burns, Alistair; Howard, Robert
title: COVID‐19 and dementia: A deadly combination
date: 2021-05-07
journal: Int J Geriatr Psychiatry
DOI: 10.1002/gps.5551
sha: 80a696342fefda2d299dd15e5bc9f389204b1e95
doc_id: 800711
cord_uid: qjl5xaq4

nan

The burden of morbidity and mortality in COVID-19 falls disproportionately on older people and those with comorbid medical conditions. 1 We described a death rate for people with dementia three times what would normally be expected for the 5-year average for April 2020, together with an increase in prescription of antipsychotic medication. 2 We now extend this observation over the subsequent course of the pandemic to highlight that a large proportion of increased COVID-19 mortality has involved people with dementia, which continues to be the commonest cause of death in England and

The Office of National Statistics produce weekly bulletins of death rates from which excess mortality rates are derived, that is, numbers of additional deaths compared to the average in previous years. We analysed these data 4 which record three different dementia diagnoses on death certificates: Alzheimer's disease, vascular dementia and unspecified dementia, which, taken together, will include most cases of dementia. Deaths within 28 days of a positive COVID-19 test are also coded as is whether dementia is the underlying cause of death or a contributory cause mentioned on the death certificate. 

Factors associated with COVID-19-related death using OpenSAFELY

Antipsychotic prescribing to people with dementia during COVID-19